INZY250117C00002500 Option on Inozyme Pharma

INZY Stock  USD 1.09  0.11  9.17%   

Inozyme Pharma Market Cap Over Time

   Market Cap   
       Timeline  

Inozyme Total Stockholder Equity

Total Stockholder Equity

87.88 Million

At this time, Inozyme Pharma's Total Stockholder Equity is fairly stable compared to the past year.

Inozyme Pharma Corporate Management

Henric BjarkeVP COOProfile
Gayle GirondaSenior OfficerProfile
MA MSAdvisor BoardProfile
FASCP MDSenior OfficerProfile
MSc MBAPresident, CoFounderProfile

Additional Tools for Inozyme Stock Analysis

When running Inozyme Pharma's price analysis, check to measure Inozyme Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme Pharma is operating at the current time. Most of Inozyme Pharma's value examination focuses on studying past and present price action to predict the probability of Inozyme Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme Pharma's price. Additionally, you may evaluate how the addition of Inozyme Pharma to your portfolios can decrease your overall portfolio volatility.